Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-25 @ 1:03 AM
NCT ID:
NCT02509793
Eligibility Criteria:
Inclusion Criteria:
* For HUntington's Disease (HD) patients only--Definite HD as indicated by positive gene testing or typical symptoms in the context of family history of HD.
* A moderate degree of impulsivity as measured by the Barrat Impulsivity Scale (BIS). (\>65)
* Must be symptomatic in the opinion of the investigator. Standard clinical criteria for symptomatic HD will be employed, any motor signs c/w HD, usually chorea.
* Patient is cognitively alert and able to answer/understand.
Exclusion Criteria:
* Patient requires the assistance of another person to walk, or is non-ambulatory.
* Patient is severely impaired cognitively.
* Patients taking neuroleptic (dopamine blocking) medications within the past 14 days.
* patient is actively suicidal, has untreated or inadequately treated depression, has impaired hepatic function, is taking MAO inhibitors or is taking reserpine or has been off of reserpine for less than 20 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02509793
Study Brief:
Protocol Section:
NCT02509793